These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

642 related articles for article (PubMed ID: 37816937)

  • 1. Mechanisms underlying HIV-associated cognitive impairment and emerging therapies for its management.
    Ellis RJ; Marquine MJ; Kaul M; Fields JA; Schlachetzki JCM
    Nat Rev Neurol; 2023 Nov; 19(11):668-687. PubMed ID: 37816937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurocognitive impairment in treatment-experienced adults living with HIV attending primary care clinics in Zimbabwe.
    Nyamayaro P; Gouse H; Hakim J; Robbins RN; Chibanda D
    BMC Infect Dis; 2020 May; 20(1):383. PubMed ID: 32471350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV Neuropathogenesis in the Presence of a Disrupted Dopamine System.
    Nickoloff-Bybel EA; Calderon TM; Gaskill PJ; Berman JW
    J Neuroimmune Pharmacol; 2020 Dec; 15(4):729-742. PubMed ID: 32506353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biotypes of Central Nervous System Complications in People With Human Immunodeficiency Virus: Virology, Immunology, and Neuropathology.
    Joseph SB; Gianella S; Burdo TH; Cinque P; Gisslen M; Letendre S; Nath A; Morgello S; Ndhlovu LC; Spudich S
    J Infect Dis; 2023 Mar; 227(Suppl 1):S3-S15. PubMed ID: 36930640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effects of Opioids on HIV Neuropathogenesis.
    Murphy A; Barbaro J; Martínez-Aguado P; Chilunda V; Jaureguiberry-Bravo M; Berman JW
    Front Immunol; 2019; 10():2445. PubMed ID: 31681322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Potential Axes of HIV Neuropathogenesis with Relevance to Biomarkers and Treatment.
    Angelovich TA; Churchill MJ; Wright EJ; Brew BJ
    Curr Top Behav Neurosci; 2021; 50():3-39. PubMed ID: 32040843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of substance abuse on HIV-mediated neuropathogenesis in the current ART era.
    Chilunda V; Calderon TM; Martinez-Aguado P; Berman JW
    Brain Res; 2019 Dec; 1724():146426. PubMed ID: 31473221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV and neurocognitive dysfunction.
    Spudich S
    Curr HIV/AIDS Rep; 2013 Sep; 10(3):235-43. PubMed ID: 23860944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aging, comorbidities, and the importance of finding biomarkers for HIV-associated neurocognitive disorders.
    Rosenthal J; Tyor W
    J Neurovirol; 2019 Oct; 25(5):673-685. PubMed ID: 30868422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EcoHIV infection of mice establishes latent viral reservoirs in T cells and active viral reservoirs in macrophages that are sufficient for induction of neurocognitive impairment.
    Gu CJ; Borjabad A; Hadas E; Kelschenbach J; Kim BH; Chao W; Arancio O; Suh J; Polsky B; McMillan J; Edagwa B; Gendelman HE; Potash MJ; Volsky DJ
    PLoS Pathog; 2018 Jun; 14(6):e1007061. PubMed ID: 29879225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alarmins and central nervous system inflammation in HIV-associated neurological disorders.
    Gougeon ML
    J Intern Med; 2017 May; 281(5):433-447. PubMed ID: 27862491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling HIV-associated neurocognitive disorders in mice: new approaches in the changing face of HIV neuropathogenesis.
    Jaeger LB; Nath A
    Dis Model Mech; 2012 May; 5(3):313-22. PubMed ID: 22563057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic Factors and Therapeutic Approaches in HIV-Associated Neurocognitive Disorders: A Comprehensive Review.
    Borrajo A; Pérez-Rodríguez D; Fernández-Pereira C; Prieto-González JM; Agís-Balboa RC
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive impairment in people living with HIV: mechanisms, controversies, and future perspectives.
    Moschopoulos CD; Alford K; Antoniadou A; Vera JH
    Trends Mol Med; 2024 Jul; ():. PubMed ID: 38955654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurocognitive dysfunction in HIV-infected youth: investigating the relationship with immune activation.
    Eckard AR; Rosebush JC; O'Riordan MA; Graves CC; Alexander A; Grover AK; Lee ST; Habib JG; Ruff JH; Chahroudi A; McComsey GA
    Antivir Ther; 2017; 22(8):669-680. PubMed ID: 28327462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Treatment Options and Randomized Clinical Trials for Neurocognitive Complications of HIV Infection: Combination Antiretroviral Therapy, Central Nervous System Penetration Effectiveness, and Adjuvants.
    Lin SP; Calcagno A; Letendre SL; Ma Q
    Curr Top Behav Neurosci; 2021; 50():517-545. PubMed ID: 33604875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral abnormalities in HIV-infected individuals with neurocognitive impairment revealed by fMRI.
    Chen PP; Wei XY; Tao L; Xin X; Xiao ST; He N
    Sci Rep; 2023 Jun; 13(1):10331. PubMed ID: 37365237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropathogenesis of HIV-associated neurocognitive disorders: roles for immune activation, HIV blipping and viral tropism.
    Chen MF; Gill AJ; Kolson DL
    Curr Opin HIV AIDS; 2014 Nov; 9(6):559-64. PubMed ID: 25203638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methamphetamine induces transcriptional changes in cultured HIV-infected mature monocytes that may contribute to HIV neuropathogenesis.
    Chilunda V; Weiselberg J; Martinez-Meza S; Mhamilawa LE; Cheney L; Berman JW
    Front Immunol; 2022; 13():952183. PubMed ID: 36059515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid (CSF) CD8+ T-cells that express interferon-gamma contribute to HIV associated neurocognitive disorders (HAND).
    Schrier RD; Hong S; Crescini M; Ellis R; Pérez-Santiago J; Spina C; Letendre S;
    PLoS One; 2015; 10(2):e0116526. PubMed ID: 25719800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.